DXM FAQ 1997: selective audit by topic

Learning materials

Which parts of William White’s DXM FAQ remain applicable, which need clarification and which explanations remain hypotheses. This section presents 29 comparisons from the 2026 audit, organized by topic.

Audit date:

What this section covers

Choose a question you recognize. Each card starts with the 2026 audit conclusion, followed by evidence, limitations and a comparison with the 1997 FAQ.

DXM, DXO and metabolism

How enzymes change the balance of DXM and DXO, and why people respond differently.

Claims: 6

Receptors and older hypotheses

What is known about NMDA, sigma-1 and sigma-2; how to read older PCP2 labels and the receptor ladder.

Claims: 8

Plateaus and comparison with ketamine

The limits of descriptive categories and the conditions of a direct comparison in research.

Claims: 2

Serotonin and interactions

Serotonin toxicity, MAO inhibitors, antidepressants and diphenhydramine.

Claims: 4

Bromism and laboratory findings

Why bromism can produce falsely high chloride and a low anion gap.

Claims: 2

The role of naloxone in poisoning

What clinical guidance says about naloxone and the limits of its effects.

Claims: 1

Dependence, withdrawal and tolerance

Published clinical cases and the origins of the claimed limit of 50.

Claims: 2

Evidence on longer-term effects

Animal experiments, MRI findings and the history of White’s withdrawal of his claims, considered separately.

Claims: 1

Formulation and ingredients

Immediate-release and extended-release DXM; additional ingredients in combination products.

Claims: 2

Modern prescription combinations

How indications for DXM combinations developed and what they cover.

Claims: 1
According to the 2026 audit

Clarifications, corrections and open questions

Decisions by audit row: 29 claims

Reviewed with the core claim retained: 4

The numbers count reviewed FAQ statements that were retained, updated, corrected or left as hypotheses. The review covers part of the FAQ.

Find a comparison by original FAQ section

Find a FAQ 4.0 section number and open the corresponding card. The audit covers only the listed passages. English titles come from the original contents.

5 · The DXM Experience 1 comparison
  1. FAQ 4.0 §5.15 · Why does DXM Affect Different People So Differently?
6 · DXM Side Effects and Other Things to Avoid 10 comparisons
  1. FAQ 4.0 §6.1 · What are Some Minor Risks of Occasional Use?
  2. FAQ 4.0 §6.2 · What are Some Major Risks of Occasional Use?
  3. FAQ 4.0 §6.3 · What Are the Risks of Regular Use and Binges?
  4. FAQ 4.0 §6.7 · Is DXM Withdrawal Dangerous?
  5. FAQ 4.0 §6.8 · Kicking the DXM Habit: What to Do If You are Addicted
  6. FAQ 4.0 §6.10 · How Toxic is DXM, and What is the Lethal Dose?
7 · Getting the Most Out of DXM 1 comparison
  1. FAQ 4.0 §7.6 · What is the "50 Trip Limit" and How Can I Avoid It?
9 · Physiological Effects of DXM 12 comparisons
  1. FAQ 4.0 §9.2 · How Does DXM Cause its Psychoactive Effects?
  2. FAQ 4.0 §9.3 · Why Does DXM Exhibit Plateaus?
  3. FAQ 4.0 §9.5 · Pharmacokinetics: How DXM is Metabolized
10 · Neuropharmacology of DXM 5 comparisons
  1. FAQ 4.0 §10.2 · What are Sigma Receptors?
  2. FAQ 4.0 §10.6 · How Does DXM Compare to Other Dissociatives at These Receptors?
  3. FAQ 4.0 §10.7 · Endopsychosin and the Big Picture
Complete FAQ 4.0 contents — 17 chapters

Original FAQ contents — for finding a section. The audit covers the passages listed above.

1 · Acknowledgements
2 · Preliminary Information
  1. FAQ 4.0 §2.1 · Restrictions and Disclaimer
  2. FAQ 4.0 §2.2 · Why a DXM FAQ?
  3. FAQ 4.0 §2.3 · Keeping DXM Legal
  4. FAQ 4.0 §2.4 · How to Use This Document
3 · DXM QuickFAQ
  1. FAQ 4.0 §3.1 · What is DXM?
  2. FAQ 4.0 §3.2 · You Mean I Can Get High Off Cough Syrup?
  3. FAQ 4.0 §3.3 · What Kinds of Cough Medicine are Safe?
  4. FAQ 4.0 §3.4 · What Happens if I Drink the Wrong Cough Syrup?
  5. FAQ 4.0 §3.5 · I'm Taking Other Drugs -- Can I Take DXM?
  6. FAQ 4.0 §3.6 · What's the DXM Trip Like?
  7. FAQ 4.0 §3.7 · How Much DXM Do I Take?
  8. FAQ 4.0 §3.8 · Is DXM Like Acid?
  9. FAQ 4.0 §3.9 · Is DXM Fun?
  10. FAQ 4.0 §3.10 · Is DXM Dangerous?
  11. FAQ 4.0 §3.11 · If DXM is Dangerous, Why Do It?
4 · General Information About DXM
  1. FAQ 4.0 §4.1 · DXM Quick Reference Page
  2. FAQ 4.0 §4.2 · What is Dextromethorphan Hydrobromide (DXM)?
  3. FAQ 4.0 §4.3 · What is Dextromethorphan Polistirex?
  4. FAQ 4.0 §4.4 · What is Dextrorphan (DXO)?
  5. FAQ 4.0 §4.5 · Is DXM Enjoyable as a Recreational Drug?
  6. FAQ 4.0 §4.6 · Is DXM an Opiate?
  7. FAQ 4.0 §4.7 · Does Everyone Like DXM?
  8. FAQ 4.0 §4.8 · How Does One Obtain and Use DXM?
  9. FAQ 4.0 §4.9 · What are Some Typical DXM-Containing Preparations?
  10. FAQ 4.0 §4.10 · How am I Supposed to Drink Cough Syrup?
  11. FAQ 4.0 §4.11 · What Should I Know About Other Drug Ingredients?
  12. FAQ 4.0 §4.12 · Why are So Many DXM Preparations in Liquid Form?
  13. FAQ 4.0 §4.13 · Is Recreational Use of DXM Illegal?
  14. FAQ 4.0 §4.14 · If DXM is Legal Why Isn't Everyone Doing It?
  15. FAQ 4.0 §4.15 · New Medical Uses for DXM
  16. FAQ 4.0 §4.16 · Drug Interactions
  17. FAQ 4.0 §4.17 · General Warnings
  18. FAQ 4.0 §4.18 · What About Other Cough Suppressants?
5 · The DXM Experience
  1. FAQ 4.0 §5.1 · What is the General Character of the DXM Experience?
  2. FAQ 4.0 §5.2 · Overview of the Lower Plateaus
  3. FAQ 4.0 §5.3 · The First Plateau
  4. FAQ 4.0 §5.4 · The Second Plateau
  5. FAQ 4.0 §5.5 · The Transitional Phase
  6. FAQ 4.0 §5.6 · The Upper Plateaus
  7. FAQ 4.0 §5.7 · The Third Plateau
  8. FAQ 4.0 §5.8 · The Fourth Plateau
  9. FAQ 4.0 §5.9 · Plateau Sigma
  10. FAQ 4.0 §5.10 · Is There Anything Beyond the Fourth Plateau?
  11. FAQ 4.0 §5.11 · What is the "DXM Third Eye Camera"?
  12. FAQ 4.0 §5.12 · Tussin Space, Tussin Consciousness
  13. FAQ 4.0 §5.13 · What is the "Tussin Euphoria" and What Makes it Unique?
  14. FAQ 4.0 §5.14 · What Can Happen with Long-term or Regular Use?
  15. FAQ 4.0 §5.15 · Why does DXM Affect Different People So Differently?
  16. FAQ 4.0 §5.16 · How Does DXM Compare With Other Dissociatives?
6 · DXM Side Effects and Other Things to Avoid
  1. FAQ 4.0 §6.1 · What are Some Minor Risks of Occasional Use?
  2. FAQ 4.0 §6.2 · What are Some Major Risks of Occasional Use?
  3. FAQ 4.0 §6.3 · What Are the Risks of Regular Use and Binges?
  4. FAQ 4.0 §6.4 · DXM and Pregnancy
  5. FAQ 4.0 §6.5 · What is NMDA Antagonist Neurotoxicity and How do I Prevent It?
  6. FAQ 4.0 §6.6 · Is DXM Addictive?
  7. FAQ 4.0 §6.7 · Is DXM Withdrawal Dangerous?
  8. FAQ 4.0 §6.8 · Kicking the DXM Habit: What to Do If You are Addicted
  9. FAQ 4.0 §6.9 · DXM Hangovers -- Avoiding and Alleviating
  10. FAQ 4.0 §6.10 · How Toxic is DXM, and What is the Lethal Dose?
  11. FAQ 4.0 §6.11 · Do You Recommend DXM for Recreational Use?
  12. FAQ 4.0 §6.12 · Help! What do I do if ...
  13. FAQ 4.0 §6.13 · How to Know When You've Done Too Much DXM
7 · Getting the Most Out of DXM
  1. FAQ 4.0 §7.1 · General Tips on Enjoying the DXM Experience
  2. FAQ 4.0 §7.2 · What are Some Fun or Interesting Things to Do on DXM?
  3. FAQ 4.0 §7.3 · Watch a Movie
  4. FAQ 4.0 §7.4 · What Tools Can Enhance the DXM Experience?
  5. FAQ 4.0 §7.5 · What are Some Things to Avoid on DXM?
  6. FAQ 4.0 §7.6 · What is the "50 Trip Limit" and How Can I Avoid It?
  7. FAQ 4.0 §7.7 · Why Can't I Hallucinate on DXM?
8 · Altered States and Paranormal Experiences
  1. FAQ 4.0 §8.1 · Preliminary Information and Discussion
  2. FAQ 4.0 §8.2 · What Paranormal and Altered State Experiences Occur on DXM?
  3. FAQ 4.0 §8.3 · Cosmic Coincidence Central and the Alien Conspiracy
  4. FAQ 4.0 §8.4 · Are These Experiences Dangerous?
  5. FAQ 4.0 §8.5 · How Can These Be Explained
  6. FAQ 4.0 §8.6 · How do I Maximize Altered States and Paranormal Experiences?
  7. FAQ 4.0 §8.7 · Factors Affecting Susceptibility to Paranormal Experiences
  8. FAQ 4.0 §8.8 · A Warning About "Spiritual Shortcuts"
  9. FAQ 4.0 §8.9 · A Warning About Temporal Lobe Epilepsy
9 · Physiological Effects of DXM
  1. FAQ 4.0 §9.1 · How Does DXM Inhibit the Cough Reflex?
  2. FAQ 4.0 §9.2 · How Does DXM Cause its Psychoactive Effects?
  3. FAQ 4.0 §9.3 · Why Does DXM Exhibit Plateaus?
  4. FAQ 4.0 §9.4 · Why is This So Complicated?
  5. FAQ 4.0 §9.5 · Pharmacokinetics: How DXM is Metabolized
10 · Neuropharmacology of DXM
  1. FAQ 4.0 §10.1 · What is a Receptor, Anyway? (Basic Neuropharmacology)
  2. FAQ 4.0 §10.2 · What are Sigma Receptors?
  3. FAQ 4.0 §10.3 · What Are NMDA Receptors?
  4. FAQ 4.0 §10.4 · What are PCP2 Receptors?
  5. FAQ 4.0 §10.5 · What are Na+ and Ca2+ Channels?
  6. FAQ 4.0 §10.6 · How Does DXM Compare to Other Dissociatives at These Receptors?
  7. FAQ 4.0 §10.7 · Endopsychosin and the Big Picture
11 · DXM Chemistry and Extraction
  1. FAQ 4.0 §11.1 · How Can I Extract DXM From Cough Syrups and Gelcaps?
  2. FAQ 4.0 §11.2 · How Can I Get Rid of Other Drug Ingredients?
  3. FAQ 4.0 §11.3 · How Can I Test for Acetaminophen?
  4. FAQ 4.0 §11.4 · How do I Use Free Base DXM?
  5. FAQ 4.0 §11.5 · How Can I Synthesize DXM?
  6. FAQ 4.0 §11.6 · What Can I Synthesize From DXM?
12 · DXM Drug Culture
  1. FAQ 4.0 §12.1 · Is There, or Was There, a DXM Drug Culture?
  2. FAQ 4.0 §12.2 · Why Haven't I Heard About DXM Drug Culture?
  3. FAQ 4.0 §12.3 · DXM "Drug Slang"
  4. FAQ 4.0 §12.4 · How do I Tell My Friends I'm Getting High off Cough Syrup?
13 · Mixing DXM and Other Drugs
  1. FAQ 4.0 §13.1 · Alcohol
  2. FAQ 4.0 §13.2 · Barbiturates and Benzodiazepines
  3. FAQ 4.0 §13.3 · Amphetamines and Other Psychostimulants
  4. FAQ 4.0 §13.4 · Cannabis (Marijuana)
  5. FAQ 4.0 §13.5 · LSD, Psilocybin (Shrooms), and Other 5HT Hallucinogens
  6. FAQ 4.0 §13.6 · Opiates
  7. FAQ 4.0 §13.7 · PCP and Ketamine
  8. FAQ 4.0 §13.8 · Nicotine
  9. FAQ 4.0 §13.9 · Phenethylamines (MDMA, MDA, 2CB, etc)
  10. FAQ 4.0 §13.10 · Nootropics (Smart Drugs)
  11. FAQ 4.0 §13.11 · Miscellaneous Other Drugs
14 · DXM Experiences and Personal Reports
  1. FAQ 4.0 §14.1 · First and Second Plateau Experiences
  2. FAQ 4.0 §14.2 · Third and Fourth Plateau Experiences
  3. FAQ 4.0 §14.3 · Long Term Use Experiences
  4. FAQ 4.0 §14.4 · Multiple Drug Experiences
15 · Appendices
  1. FAQ 4.0 §15.1 · Appendix 1: P450 Inhibiting Drugs
  2. FAQ 4.0 §15.2 · Appendix 2: Neuropharmacology of Recreational Drugs
  3. FAQ 4.0 §15.3 · Appendix 3: Other Sigma and NMDA Ligands
16 · Glossary
17 · References
FAQ edition and review coverage

DXM FAQ text version 4.0 has an introduction dated 15 March 1997. Links lead to Erowid’s HTML archive (4.0-Y.1), which contains later edits. Modern-source checking covers abstracts of 26 journal papers and selected sections of articles, archives and official documents; not all full texts were read. AI was used to prepare and check the translation and cards, and to check sources. Independent scientific peer review was not performed.

Historical points are presented as brief paraphrases. The main interaction review and its PHI ratings have their own sources.

William White’s archived DXM FAQ

33 FAQ audit references with independent numbering

[1] William White — historical DXM FAQ

[2] Lutz — DXM metabolism

[3] Rüdesheim — pharmacokinetic model

[4] Capon — CYP2D6 activity

[5] Caudle — CYP2D6 genotype and phenotype

[6] Zawertailo — metabolism and effects

[7] Zawertailo — CYP2D6 inhibition

[8] Xiao — DXM and DXO target binding

[9] Meoni — DM2 binding sites

[10] Schmidt — sigma-1 structure

[11] Alon — sigma-2 and TMEM97

[12] Nguyen — mouse model

[13] Carbonaro — DXM effects in humans

[14] Shram — ketamine comparison

[15] Monte — serotonin toxicity

[16] Harada — DXM and moclobemide

[17] Hamelin — diphenhydramine and CYP2D6

[18] Gillman — serotonin toxicity

[19] Delsym — polistirex label

[20] Ng — bromism

[21] Carliss — oral DXM in rats

[22] Tran — cellular changes in rats

[23] White — withdrawal of neurotoxicity claims

[24] Qiu — MRI in DXM dependence

[25] Mutschler — dependence and withdrawal

[26] Olives — prolonged use and tolerance

[27] Chyka — clinical poisoning guideline

[28] Nuedexta — historical FDA label

[29] Auvelity — current label

[30] FDA — new Auvelity indication

[31] Axsome — AXS-05 program announcement

[32] Di Marco — juices and DXM pharmacokinetics

[33] Strauch — grapefruit juice and DXM metabolites

Brief history: 9 statements from the older FAQ

Reference

Open the source and related combinations →